期刊文献+

可逆性后部白质脑病综合征临床探讨 被引量:11

下载PDF
导出
摘要 目的探讨可逆性后部白质性脑病综合征(RPLS)的病因、临床表现、影像学特征及治疗。方法总结分析8例可逆性后部白质脑病综合征患者的发病原因、临床症状、影像学检查特点、治疗及预后。结果8例患者经针对病因治疗(如降压、止痉、停止使用免疫抑制药物、化疗药、停止放疗、控制肺部感染)及酌情使用甘露醇、呋噻米等脱水降颅压药物,症状与体征恢复至发病前6例,基本消失2例。结论可逆性后部白质脑病综合征是一种有特征临床和影像学检查表现的临床综合征,及时就诊、尽早治疗,一般预后良好。
作者 张九成
出处 《中国实用神经疾病杂志》 2010年第2期37-38,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献9

  • 1郑茜,王为珍,祝茗,赵永波.可逆性后部白质脑病综合征临床分析[J].上海医学,2007,30(8):592-594. 被引量:9
  • 2Hinchey J, Chaves C, Appgnani B, et al. A reversible posterior leukoencephalopathy syndrome[J]. N Engl JMed, 1996, 334 (8) :494.
  • 3Shin KC,Choi H J, Bae YD, et al. Reversible posterior leukoencephalopathy syndrome in systemic Xupus erythematosus with thrombocytopenia treated with eyclosporine[J]. J Clin Rheumatol,2005,11(3) : 164-166.
  • 4李桂香,董林森,王运良.全脑缺血后脑损伤的机制[J].中国实用神经疾病杂志,2008,11(11):126-129. 被引量:6
  • 5Banerjee AK. Posteiror leukoencephalopathy syndrome [J].Postgraduate Medical Journal, 2001,77 : 551.
  • 6Potr JD, Beauchamp NJ. Reversible intracerebral pathologic entities mediated by vascular autoergulatory dysfunetion[J]. Radiographics, 1998,18 : 353-367.
  • 7D' Angelo P, Farruggia P, Lo Bello A, et al. Reversible posterior leukoencephalopathy syndrome : report of 2 simultaneous cases in children[J]. J Pediatr Hematol Oncol,2006,28(3) :177-181.
  • 8Ozcakar ZB, Ekim M, Fitoz S, et al. Hypertension induced revesrible posteiror leukoencephalopathy syndrome: a report of two cases[J]. Eur J Pediatr,2004,163(12):728-730.
  • 9Kitaguchi H, Tomimoto H, Miki Y, et al. A brainstem vairant of revesrible posteiror leukoencephalopathy syndrome[J].Neuorradiology, 2005,47 (9) :652-656.

二级参考文献19

  • 1[1]Bhardwaj A,Alkayed NJ,Kirsch JR,et al.Mechanisms of ischemic brain damage[J].Curr Cardiol Rep,2003,5,160-170.
  • 2[2]Nussmeier NA,A review of risk factors for adverse neurologic outcome after cardiac surgery[J].J Extra Corpor Technol,2002,34,4-10.
  • 3[3]Koehler RC,Eleff SM,Traystman R J,et al.Global neuronal ischemia and reperfusion[J].Williams and Wilkins,1996,113-45.
  • 4[4]Sugawara T,Fujimura M,Noshita N,et al.Neuronal death/survival signaling pathways in cerebral ischemia[J].Neuro Rx,2004,1:17-25.
  • 5[5]Han HS,Yenari MA.Cellular targets of brain inflammation in stroke[J].Curr Opin Investig Drug,2003,4,522-529.
  • 6[6]Danton GH,Dietrich WD.Inflammation mechanisms after ischemia and stroke[J].J Neuropathol Exp Neurol,2003,62:127-136.
  • 7[7]Ding C,He Q,Li PA.Activation of cell death pathway after a brief period of global ischemia in diabetic and nondiabetic animals[J].Exp Neurol,2004,188,421-429.
  • 8[8]Weigl M,Tenze G,Steinlecchner B,et al.A systematic review of currently available pharmacological neuroprotective agents as s sole intervention before anticipated or induced cardiac arrest[J].Resuscitation,2005,65,21-39
  • 9[9]Goyagi T,Bhardwaj A,Koehler RC,et al.Potent sigma 1-receptor ligand 4-phenyl-1-piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats[J].Anesth Analg,2003,96,532-538
  • 10Hinchey J,Chaves C,Appignani B,et al.A reversible posterior leukoencephalopathy syndrome.N Engl J Med,1996,334:494-500.

共引文献12

同被引文献70

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部